150 related articles for article (PubMed ID: 14520705)
41. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
42. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
Truin W; Vugts G; Roumen RM; Maaskant-Braat AJ; Nieuwenhuijzen GA; van der Heiden-van der Loo M; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2016 Jan; 23(1):51-7. PubMed ID: 25980321
[TBL] [Abstract][Full Text] [Related]
43. Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer.
Pramod N; Nigam A; Basree M; Mawalkar R; Mehra S; Shinde N; Tozbikian G; Williams N; Majumder S; Ramaswamy B
Oncologist; 2021 Jun; 26(6):e943-e953. PubMed ID: 33641217
[TBL] [Abstract][Full Text] [Related]
44. Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast.
Arps DP; Jorns JM; Zhao L; Bensenhaver J; Kleer CG; Pang JC
Ann Surg Oncol; 2014 Dec; 21(13):4152-8. PubMed ID: 24980090
[TBL] [Abstract][Full Text] [Related]
45. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathological features of invasive lobular carcinoma of the breast: A nationwide multicenter study in China.
Zhu MZ; Yu XF; He XM; Feng WL; Fan JH; Li J; Xu F; Tang ZH; Zhang BN; Qiao YL; Zheng S; Yang HJ
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C89-94. PubMed ID: 26323933
[TBL] [Abstract][Full Text] [Related]
47. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
48. Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
Wang K; Zhu GQ; Shi Y; Li ZY; Zhang X; Li HY
Clin Breast Cancer; 2019 Feb; 19(1):e101-e115. PubMed ID: 30502219
[TBL] [Abstract][Full Text] [Related]
49. Risk factors for ductal and lobular breast cancer: results from the nurses' health study.
Kotsopoulos J; Chen WY; Gates MA; Tworoger SS; Hankinson SE; Rosner BA
Breast Cancer Res; 2010; 12(6):R106. PubMed ID: 21143857
[TBL] [Abstract][Full Text] [Related]
50. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
Jayasinghe UW; Bilous AM; Boyages J
Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
[TBL] [Abstract][Full Text] [Related]
51. Hormone replacement therapy in relation to breast cancer.
Chen CL; Weiss NS; Newcomb P; Barlow W; White E
JAMA; 2002 Feb; 287(6):734-41. PubMed ID: 11851540
[TBL] [Abstract][Full Text] [Related]
52. The effect of length of birth interval on the risk of breast cancer by subtype in grand multiparous women.
Katuwal S; Tapanainen JS; Pukkala E; Kauppila A
BMC Cancer; 2019 Mar; 19(1):199. PubMed ID: 30832620
[TBL] [Abstract][Full Text] [Related]
53. Alcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 Years.
Baglia ML; Malone KE; Tang MC; Li CI
Horm Cancer; 2017 Aug; 8(4):211-218. PubMed ID: 28567703
[TBL] [Abstract][Full Text] [Related]
54. A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States).
Cook LS; White E; Schwartz SM; McKnight B; Daling JR; Weiss NS
Cancer Causes Control; 1996 May; 7(3):382-90. PubMed ID: 8734833
[TBL] [Abstract][Full Text] [Related]
55. The Pathologic Finding of Combined Lobular Carcinoma
Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
[TBL] [Abstract][Full Text] [Related]
56. Do reproductive factors influence T, N, and M classes of ductal and lobular breast cancers? A nation-wide follow-up study.
Mousavi SM; Försti A; Sundquist K; Hemminki K
PLoS One; 2013; 8(5):e58867. PubMed ID: 23734170
[TBL] [Abstract][Full Text] [Related]
57. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.
Zhao H; Langerød A; Ji Y; Nowels KW; Nesland JM; Tibshirani R; Bukholm IK; Kåresen R; Botstein D; Børresen-Dale AL; Jeffrey SS
Mol Biol Cell; 2004 Jun; 15(6):2523-36. PubMed ID: 15034139
[TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance mammography of invasive lobular versus ductal carcinoma: systematic comparison of 811 patients reveals high diagnostic accuracy irrespective of typing.
Dietzel M; Baltzer PA; Vag T; Gröschel T; Gajda M; Camara O; Kaiser WA
J Comput Assist Tomogr; 2010 Jul; 34(4):587-95. PubMed ID: 20657229
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
Phipps AI; Li CI; Kerlikowske K; Barlow WE; Buist DS
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1643-54. PubMed ID: 20501751
[TBL] [Abstract][Full Text] [Related]
60. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.
Li CI; Daling JR; Haugen KL; Tang MT; Porter PL; Malone KE
Breast Cancer Res Treat; 2014 Jun; 145(2):481-9. PubMed ID: 24748570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
